{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T07:10:56Z","timestamp":1761030656541,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.spen.2023.101073","type":"journal-article","created":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T20:27:06Z","timestamp":1691353626000},"page":"101073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comment: Amenable Treatable Severe Pediatric Epilepsies"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6373-1068","authenticated-orcid":false,"given":"Phillip L.","family":"Pearl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.spen.2023.101073_bib0001","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.spen.2016.06.004","article-title":"Amenable treatable severe pediatric epilepsies","volume":"23","author":"Pearl","year":"2016","journal-title":"Sem Pediatr Neurol"},{"first-page":"356","year":"2013","series-title":"Inherited Metabolic Epilepsies","key":"10.1016\/j.spen.2023.101073_bib0002"},{"first-page":"544","year":"2018","series-title":"Inherited Metabolic Epilepsies","key":"10.1016\/j.spen.2023.101073_bib0003"},{"issue":"2","key":"10.1016\/j.spen.2023.101073_bib0004","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1542\/peds.13.2.140","article-title":"Pyridoxine dependency: Report of a case of intractable convulsions in an infant controlled by pyridoxine","volume":"13","author":"Hunt","year":"1954","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2023.101073_bib0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm1366","article-title":"Mutations in antiquitin in individuals with pyridoxine-dependent seizures","volume":"12","author":"Mills","year":"2006","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.spen.2023.101073_bib0006","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/hmg\/ddi120","article-title":"Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5\u2019-phosphate oxidase","volume":"14","author":"Mills","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.spen.2023.101073_bib0007","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejpn.2022.06.006","article-title":"Urgent unmet need for pharmaceutical grade vitamin therapy in pyridoxine dependent epilepsies","volume":"39","author":"Pearl","year":"2022","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.spen.2023.101073_bib0008","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1212\/WNL.0000000000207133","article-title":"New therapeutic approaches to inherited metabolic pediatric epilepsies","volume":"101","author":"Pearl","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2023.101073_bib0009","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/epi.12954","article-title":"Diagnostic yield of genetic testing in epileptic encephalopathy in childhood","volume":"56","author":"Mercimek-Mahmutoglu","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2023.101073_bib0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/gim.2012.144","article-title":"Comprehensive next-generation sequence analyses of the entire mitochondrial genome reveal new insights into the molecular diagnosis of mitochondrial DNA disorders","volume":"15","author":"Cui","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.spen.2023.101073_bib0011","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/jimd.12332","article-title":"Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to alpha-aminoadipic semialdehyde dehydrogenase deficiency","volume":"44","author":"Coughlin","year":"2021","journal-title":"I Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.spen.2023.101073_bib0012","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2018.03.006","article-title":"Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)","volume":"124","author":"Thomas","year":"2018","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.spen.2023.101073_bib0013","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.omtn.2022.02.020","article-title":"Development of an mRNA replacement therapy for phenylketonuria","volume":"28","author":"Perez-Garcia","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.spen.2023.101073_bib0014","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.biochi.2019.12.007","article-title":"Classical homocystinuria: from cystathionine beta-synthase deficiency to novel enzyme therapies","volume":"173","author":"Bublil","year":"2020","journal-title":"Biochimie"},{"issue":"6","key":"10.1016\/j.spen.2023.101073_bib0015","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/jimd.12437","article-title":"Long-term functional correction of cystathionine beta-synthase deficiency in mice by adeno-associated viral gene therapy","volume":"44","author":"Lee","year":"2021","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"10.1016\/j.spen.2023.101073_bib0016","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/jimd.12534","article-title":"Treatment of metabolic disorders using genomic technologies: Lessons from methylmalonic academia","volume":"45","author":"Venturoni","year":"2022","journal-title":"J Inherit Metab Dis"},{"issue":"20","key":"10.1016\/j.spen.2023.101073_bib0017","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"Study of intraventricular cerliponase alfa for CLN2 disease","volume":"378","author":"Schulz","year":"2018","journal-title":"N Engl J Med"},{"issue":"10007","key":"10.1016\/j.spen.2023.101073_bib0018","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0140-6736(15)00124-5","article-title":"Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type A: A prospective cohort study","volume":"386","author":"Schwahn","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.spen.2023.101073_bib0019","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/brain\/aww300","article-title":"CAD mutations and uridine-responsive epileptic encephalopathy","volume":"140","author":"Koch","year":"2017","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.spen.2023.101073_bib0020","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1038\/s41467-021-24524-8","article-title":"Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons","volume":"12","author":"Pearson","year":"2021","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.spen.2023.101073_bib0021","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ymthe.2021.11.005","article-title":"Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency","volume":"30","author":"Tai","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.spen.2023.101073_bib0022","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/acn3.696","article-title":"Age-related phenotype and biomarker changes in SSADH deficiency","volume":"6","author":"DiBacco","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.spen.2023.101073_bib0023","doi-asserted-by":"crossref","DOI":"10.1111\/dmcn.15659","article-title":"Autism spectrum disorder and GABA levels in children with succinic semialdehyde dehydrogenase deficiency","author":"Tokatly Latzer","year":"2023","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"10.1016\/j.spen.2023.101073_bib0024","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/epi.17592","article-title":"The presence and severity of epilepsy coincide with reduced \u03b3-aminobutyrate and cortical excitatory markers in succinic semialdehyde dehydrogenase deficiency","volume":"64","author":"Tokatly Latzer","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2023.101073_bib0025","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3390\/ijms23052606","article-title":"Understanding the molecular mechanisms of succinic semialdehyde dehydrogenase deficiency (SSADHD): Towards the development of SSADH-targeted medicine","volume":"23","author":"Lee","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.spen.2023.101073_bib0026","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jimd.12251","article-title":"Aartsma-Rus A. opportunities and challenges for antisense oligonucleotide therapies","volume":"44","author":"Kuijper","year":"2021","journal-title":"J Inherit Metab Dis"},{"issue":"13-14","key":"10.1016\/j.spen.2023.101073_bib0027","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/0883073820981262","article-title":"Succinic semialdehyde dehydrogenase deficiency: Review of the natural history study","volume":"36","author":"Pearl","year":"2021","journal-title":"J Child Neurol"},{"issue":"9","key":"10.1016\/j.spen.2023.101073_bib0028","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1038\/npp.2016.17","article-title":"40 Hz auditory steady-state response is a pharmacodynamics biomarker for cortical NMDA receptors","volume":"41","author":"Sivarao","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.spen.2023.101073_bib0029","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41398-021-01451-2","article-title":"Transcranial magnetic stimulation as a translational biomarker for AMPA receptor modulation","volume":"11","author":"O'Donnell","year":"2021","journal-title":"Transl Psychiatry"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909123000426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909123000426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:39:30Z","timestamp":1761028770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909123000426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":29,"alternative-id":["S1071909123000426"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2023.101073","relation":{},"ISSN":["1071-9091"],"issn-type":[{"type":"print","value":"1071-9091"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment: Amenable Treatable Severe Pediatric Epilepsies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2023.101073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101073"}}